Competitor Analysis: FSH, hCG and LH - Therapeutic Proteins for Assisted Reproductive Technology (ART)

Publisher: La Merie Publishing
Pages: 43
Format: PDF
Product Line:
Competitor Analysis
Product Code: LMCA0035
Release Date: February of 2013

250.00 €
Free of 21 % VAT (except in Spain and also in the European Union without valid intl. VAT no),
Delivery costs do not apply or are included.
You can also order this product via email or fax , please download the Order Form
Need more information?
Ask a question about this product

FSH, hCG and LH: Therapeutic Proteins for Assisted Reproductive Technology (ART)

Product description

The Competitive Intelligence Report FSH, hCG and LH: Therapeutic Proteins for Assisted Reproductive Technology (ART) as of February 2013 provides a competitor analysis in the development pipeline of novel recombinant and purified FSH, hCG and LH receptor agonists for treatment of infertility. Purchase of the downloadable pdf report includes a 6-month online access to the data of the report and any updates since the publication date. Credentials to access the database will be sent by e-mail and allow online work with the project data to print or export an individual report.

The report provides information on the marketed FSH, hCG and LH preparations and includes a compilation of current active projects in research and development of novel FSH, LH and hCG receptor agonists. In addition, the report lists company-specific R&D pipelines of FSH, LH and hCG products and projects. Competitor projects are listed in a tabular format providing information on:

  • Drug Codes,
  • Target / Mechanism of Action,
  • Class of Compound,
  • Company,
  • Product Category,
  • Indication,
  • R&D Stage and
  • additional comments with a hyperlink leading to the source of information.

About Competitor Analysis Series:

The Competitor Analysis Series delivers NO-FRILLS, but concise information about the pipeline of R&D projects for targets, diseases, technologies and companies at low prices. The information is provided in a tabular format and fully referenced.


FSH, hCG and LH: Therapeutic Proteins for Assisted Reproductive Technology (ART)

Table of Contents

  • Urinary FSH-Containing Products: Menotropins
  • Recombinant Menotropins
  • 1st Generation Purified Human Urinary FSH
  • 2nd Generation Recombinant Human FSH
  • Biosimilar Recombinant Human FSH
  • 2nd Generation Rhu FSH in Non-Regulated Markets
  • 3rd Generation Rhu FSH
  • Purified Urinary Human Choriogonadotropin (hCG)
  • Recombinant Human Choriogonadotropin (rhCG)
  • Recombinant Human Luteinizing Hormone (rhLH)
  • hCG Receptor Agonist
  • Corporate FSH, LH and hCG Product Portfolios and R&D Pipelines


The above shown price refers to a Single User License. Please contact us for prices of departmental, site or global product licenses.

This Report is NOT a downloadable item but will be delivered via email within 24 h (working days only).

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2021 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up